Charles River Laboratories International, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $163.8M | $117.6M | $117.9M | $160.0M | $155.9M | $109.7M | $68.9M | $179.2M |
| Accounts Receivable | $430.0M | $364.1M | $270.1M | $258.0M | $220.6M | $203.0M | $184.8M | $193.0M |
| Inventory | $115.0M | $95.8M | $93.7M | $89.0M | $89.4M | $88.5M | $93.0M | $100.3M |
| Total Current Assets | $826.6M | $656.8M | $559.2M | $579.3M | $552.6M | $485.3M | $425.8M | $552.9M |
| Property, Plant & Equipment | $782.0M | $755.8M | $678.0M | $676.8M | $676.2M | $717.0M | $738.0M | $752.7M |
| Goodwill | $804.9M | $787.5M | $438.8M | $321.1M | $230.7M | $208.6M | $197.6M | $198.4M |
| Intangible Assets (Excl. Goodwill) | $369.8M | $394.4M | $280.8M | $178.9M | $84.5M | $84.9M | $93.4M | $121.2M |
| Total Assets | $2.93B | $2.71B | $2.07B | $1.87B | $1.63B | $1.59B | $1.56B | $1.73B |
| Liabilities | ||||||||
| Accounts Payable | $77.8M | $68.5M | $36.7M | $33.8M | $31.8M | $31.2M | $34.3M | $30.6M |
| Total Current Liabilities | $463.5M | $429.6M | $311.8M | $294.7M | $247.0M | $342.2M | $216.8M | $259.8M |
| Long-Term Debt | $1.09B | $1.19B | $821.0M | $722.0M | $641.8M | $527.1M | $703.2M | $670.2M |
| Total Liabilities | $1.87B | $1.86B | $1.30B | $1.17B | $968.1M | $983.1M | $1.03B | $1.04B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $288.7M | $165.3M | $10.5M | $-138.8M | $-265.5M | $-368.3M | $-465.6M | $-575.2M |
| Total Stockholders' Equity | $1.05B | $836.8M | $733.1M | $672.2M | $641.0M | $600.8M | $525.6M | $687.4M |